Cabazitaxel - PF Induction Chemotherapy

NCT01379339 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Cabazitaxel 10mg/m2
DRUG: Cabazitaxel 12.5mg/m2
DRUG: Cabazitaxel 15mg/m2
DRUG: Cabazitaxel 17.5mg/m2
DRUG: Cabazitaxel 20mg/m2

Sponsor

Krzysztof Misiukiewicz

Collaborators

[object Object]
[object Object]